Sponsor or institution

Clinical trials and research at Shenzhen University General Hospital

• 9Clinical trials
• 1Country

Newest trials

All recruiting trials (9)

• CD19-targeted CAR-T cells that make p40 for relapsed or refractory CD19-positive blood cancers

  This trial will try a patient's own CD19-directed CAR-T cells engineered to produce p40 to see if they work better and last longer in adults with relapsed or refractory CD19-positive blood cancers.

  Recruiting Phase 1/2 Shenzhen University General Hospital · Shenzhen, Other (Non U.s.) · NCT07584889

• Bugitinib with venetoclax and cytarabine for relapsed or refractory acute myeloid leukemia

  This trial tests whether the three-drug combination of bugitinib, venetoclax, and cytarabine can clear minimal residual disease in adults with relapsed or refractory AML.

  Recruiting Phase 2 Shenzhen University General Hospital · Shenzhen, Guangdong · NCT07563179

• CD19/CD20 CAR/TRuC-T for relapsed or refractory B‑cell lymphoma

  This trial will try a single infusion of CD19/CD20 CAR/TRuC-T cells after short lymphodepleting chemotherapy in adults with relapsed or refractory B‑cell lymphoma to see if it is safe and can shrink tumors.

  Recruiting Phase 1/2 Shenzhen University General Hospital · Shenzhen, Guangdong · NCT07508605

• MSLN CAR-T for advanced malignant tumors

  This trial will test whether a single infusion of MSLN-targeted CAR-T cells is safe and can shrink tumors in adults (18–75) with stage III/IV solid cancers that express mesothelin.

  Recruiting Phase 1/2 Shenzhen University General Hospital · Shenzhen, Other (Non U.s.) · NCT07399769

• Autocrine p40 CD19/CD20 dual-targeting CAR-T therapy for relapsed or refractory B-cell lymphoma

  This will test a dual-targeting CD19/CD20 autocrine p40 CAR-T cell treatment in adults whose B-cell lymphoma has returned or not responded to prior therapies.

  Recruiting Phase 1/2 Shenzhen University General Hospital · Shenzhen, Other (Non U.s.) · NCT07097207

• Treatment for advanced pancreatic and gastric cancers using Claudin18.2 CAR-T cells

  This study tests a new CAR-T cell treatment for people with advanced pancreatic and gastric cancers to see if it can help them after other treatments have not worked.

  Recruiting Shenzhen University General Hospital · Shenzhen, Guangdong · NCT05620732

• Using GPC-3 CAR-T cells to treat advanced liver cancer

  This study is testing a new type of immune therapy using GPC-3 CAR-T cells to see if it can help people with advanced liver cancer who have run out of other treatment options.

  Recruiting Shenzhen University General Hospital · Shenzhen, Guangdong · NCT05620706

• Treatment for advanced soft tissue sarcoma using NY-ESO-1 TCR-T cells

  This study is testing a new treatment using specially designed immune cells to see if it can help people with advanced soft tissue sarcoma who haven't had success with other treatments.

  Recruiting Shenzhen University General Hospital · Shenzhen, Guangdong · NCT05620693

• Using CD7 CAR-T cells to treat T-cell lymphoma and leukemia

  This study is testing a new type of treatment using CD7 CAR-T cells to see if it can help adults with T-cell lymphoma and leukemia who haven't had success with other therapies.

  Recruiting Shenzhen University General Hospital · Shenzhen, Guangdong · NCT05620680

Quick answers

How many clinical trials run by Shenzhen University General Hospital are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 4, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →